| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 49,546 | 50,174 | 48,190 | 53,644 | | Cost of Revenue | 32,786 | 33,184 | 31,937 | 35,435 | | | Gross Profit | 16,760 | 16,990 | 16,253 | 18,209 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,060 | 3,404 | 3,250 | 3,373 | | Non Recurring |
-
|
-
|
-
| 41,725 | | Others | 6,714 | 6,841 | 6,532 | 7,013 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 6,986 | 6,745 | 6,471 | (33,902) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (859) | (449) | (349) | (7,146) | | Earnings Before Interest And Taxes | 6,127 | 6,296 | 6,122 | (41,048) | | Interest Expense | 4,511 | 4,555 | 4,459 | 3,264 | | Income Before Tax | 1,616 | 1,741 | 1,663 | (44,312) | | Income Tax Expense | 790 | 908 | 1,099 | (15,305) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 826 | 833 | 564 | (29,007) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 826 | 833 | 564 | (29,007) | | Preferred Stock And Other Adjustments | (1,076) | (1,062) | (1,054) | (1,035) | | | Net Income Applicable To Common Shares | ($250) | ($229) | ($490) | ($30,042) |
|
0.09% Nasdaq 
0.36%
Income Statement
